The EU-MERCOSUR trade agreement and its impact on CO2 emissions

Artículo de revistaIn 2019 the European Union (EU) and the Latin American countries that make up the Common Market of the South (Mercosur) reached a political agreement to sign, ratify and implement a trade agreement between the two blocs. This agreement is expected to bring trade and welfare benefits on both sides of the Atlantic. The impact estimated for the EU will be similar to that of other recent agreements, such as that entered into with Japan. However, the EU-Mercosur “agreement in principle” has raised concerns owing to its potential impact on the environment and climate, even though it includes strict provisions in these areas and entails very few changes to the tariff and non-tariff measures adopted for agricultural imports from Mercosur. This article focuses on a specific aspect of the EU-Mercosur agreement’s potential environmental impact, namely, the change envisaged in global CO2 emissions. Despite the uncertainty associated with such estimations, when using a standard general equilibrium model, the increase in CO2 emissions deriving from this agreement is found to be limited. Moreover, in certain plausible scenarios, application of the very stringent environmental standards provided for in the agreement in principle could even lower emissions in Mercosur countries

Transmission of Helium through Graphynes Pores: First Principles Calculations and Quantum Mechanical Simulations

AMOC 2015, Anharmonicity in médium-sized molecules and cluster, CSIC, Madrid (Spain), 26-30 April 2015; http://tct1.iem.csic.es/AMOC2015.htmPeer Reviewe

El acuerdo comercial UE-MERCOSUR y su impacto sobre las emisiones de CO2

Artículo de revistaEn 2019, la Unión Europea (UE) y los países latinoamericanos que forman el Mercado Común del Sur (MERCOSUR) alcanzaron un acuerdo político para la firma, ratificación e implementación de un tratado comercial entre los dos bloques. Se espera que dicho acuerdo genere beneficios comerciales y de bienestar en ambos lados del Atlántico. En el caso de la UE, se estiman impactos similares a los que se han identificado en el caso de otros acuerdos recientes, como el firmado con Japón. No obstante, el «principio de acuerdo» UE-MERCOSUR ha suscitado preocupación por sus potenciales impactos medioambientales y climáticos, a pesar de incluir disposiciones rigurosas en ese ámbito, y de conllevar cambios muy limitados en las medidas arancelarias y no arancelarias relacionadas con las importaciones de productos agrícolas procedentes del MERCOSUR. Este artículo se centra en un aspecto específico de esos posibles impactos medioambientales del acuerdo UE-MERCOSUR: el cambio esperado en las emisiones globales de CO2. Dentro de la incertidumbre asociada a la estimación de estos impactos, a partir de un modelo de equilibrio general estándar en la literatura, se encuentra que el aumento de las emisiones de CO2 derivado de este acuerdo sería limitado. Además, en algunos escenarios plausibles, la aplicación de las normativas medioambientales del principio de acuerdo —muy estrictas— podrían incluso conllevar un descenso de las emisiones en los países del MERCOSUR

Fractionation of Lignocellulosic Biomass by Selective Precipitation from Ionic Liquid Dissolution

We propose the treatment of barley straw with 1-ethyl-3-methylimidazolium acetate [EMIMAcO] ionic liquids (ILs) and subsequent precipitation with antisolvent mixtures, thus allowing the separation of the sugar-rich fractions (cellulose and hemicellulose) from the lignin fraction. For this purpose, different concentration ranges of acetone:water antisolvent mixtures were studied. In all cases, a high recovery percentage and a high and effective separation of fractions was achieved for 1:1 acetone:water. The fractionated lignocellulosic compounds were studied by using infrared spectroscopy, scanning electron microscopy and 1H nuclear magnetic resonance characterization techniques. This method allows the possibility of reusing IL, confirming the versatility of the established method. The fraction rich in cellulose and hemicellulose was subjected to acid hydrolysis (0.2 mol/L H2SO4) for 5 h at 140 °C, obtaining a yield of total reducing sugars of approximately 80%, much higher than those obtained in non-pretreated samples.This research was funded by Comunidad de Madrid (Spain) and ERDF (European Regional Development Fund), grant numbers S2013/MAE-2882 (RESTOENE-2-CM), S2018/EMT-4344 (BIOTRES-CM) and CSIC (201880E029). M.L.-S. acknowledges the support of the European Social Fund and Community of Madrid for her contracPeer reviewe

Comparação dos Fluxos Noturnos de Co2 e Calor Sensível em Manaus e São Gabriel da Cachoeira

Comparação dos fluxos noturnos de CO2 e calor sensívelem Manaus e São Gabriel da Cachoeir

Primary constitutional MLH1 epimutations: a focal epigenetic event

BACKGROUND: Constitutional MLH1 epimutations are characterised by monoallelic methylation of the MLH1 promoter throughout normal tissues, accompanied by allele-specific silencing. The mechanism underlying primary MLH1 epimutations is currently unknown. The aim of this study was to perform an in-depth characterisation of constitutional MLH1 epimutations targeting the aberrantly methylated region around MLH1 and other genomic loci. METHODS: Twelve MLH1 epimutation carriers, 61 Lynch syndrome patients, and 41 healthy controls, were analysed by Infinium 450 K array. Targeted molecular techniques were used to characterise the MLH1 epimutation carriers and their inheritance pattern. RESULTS: No nucleotide or structural variants were identified in-cis on the epimutated allele in 10 carriers, in which inter- generational methylation erasure was demonstrated in two, suggesting primary type of epimutation. CNVs outside the MLH1 locus were found in two cases. EPM2AIP1-MLH1 CpG island was identified as the sole differentially methylated region in MLH1 epimutation carriers compared to controls. CONCLUSION: Primary constitutional MLH1 epimutations arise as a focal epigenetic event at the EPM2AIP1-MLH1 CpG island in the absence of cis-acting genetic variants. Further molecular characterisation is needed to elucidate the mechanistic basis of MLH1 epimutations and their heritability/reversibility

Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients

Fanconi anemia (FA) is caused by biallelic mutations in FA genes. Monoallelic mutations in five of these genes (BRCA1, BRCA2, PALB2, BRIP1 and RAD51C) increase the susceptibility to breast/ovarian cancer and are used in clinical diagnostics as bona-fide hereditary cancer genes. Increasing evidence suggests that monoallelic mutations in other FA genes could predispose to tumor development, especially breast cancer. The objective of this study is to assess the mutational spectrum of 14 additional FA genes (FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FANCP, FANCQ, FANCR and FANCU) in a cohort of hereditary cancer patients, to compare with local cancer-free controls as well as GnomAD. A total of 1021 hereditary cancer patients and 194 controls were analyzed using our next generation custom sequencing panel. We identified 35 pathogenic variants in eight genes. A significant association with the risk of breast cancer/breast and ovarian cancer was found for carriers of FANCA mutations (odds ratio (OR) = 3.14 95% confidence interval (CI) 1.4-6.17, p = 0.003). Two patients with early-onset cancer showed a pathogenic FA variant in addition to another germline mutation, suggesting a modifier role for FA variants. Our results encourage a comprehensive analysis of FA genes in larger studies to better assess their role in cancer risk

Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

[Background] The value of the single-breath diffusing capacity of the lungs for carbon monoxide (Dlco) relates to outcomes for patients with COPD. However, little is known about the natural course of Dlco over time, intersubject variability, and factors that may influence Dlco progression.[Research Question] What is the natural course of Dlco in patients with COPD over time, and which other factors, including sex differences, could influence this progression?[Study Design and Methods] We phenotyped 602 smokers (women, 33%), of whom 506 (84%) had COPD and 96 (16%) had no airflow limitation. Lung function, including Dlco, was monitored annually over 5 years. A random coefficients model was used to evaluate Dlco changes over time.[Results] The mean (± SE) yearly decline in Dlco % in patients with COPD was 1.34% ± 0.015%/y. This was steeper compared with non-COPD control subjects (0.04% ± 0.032%/y; P = .004). Sixteen percent of the patients with COPD, vs 4.3% of the control subjects, had a statistically significant Dlco % slope annual decline (4.14%/y). At baseline, women with COPD had lower Dlco values (11.37% ± 2.27%; P < .001) in spite of a higher FEV1 % than men. Compared with men, women with COPD had a steeper Dlco annual decline of 0.89% ± 0.42%/y (P = .039).[Interpretation] Patients with COPD have an accelerated decline in Dlco compared with smokers without the disease. However, the decline is slow, and a testing interval of 3 to 4 years may be clinically informative. The lower and more rapid decline in Dlco values in women, compared with men, suggests a differential impact of sex in gas exchange function.[Trial Registry] ClinicalTrials.gov; No.: NCT01122758; URL: www.clinicaltrials.govThis study was funded in part by an unrestricted grant from AstraZeneca, and also by the COPD Research Program of the Spanish Respiratory Society (PII de EPOC of SEPAR).Peer reviewe

Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals

The causal mechanism for cancer predisposition in Lynch-like syndrome (LLS) remains unknown. Our aim was to elucidate the constitutional basis of mismatch repair (MMR) deficiency in LLS patients throughout a comprehensive (epi)genetic analysis. One hundred and fifteen LLS patients harboring MMR-deficient tumors and no germline MMR mutations were included. Mutational analysis of 26 colorectal cancer (CRC)-associated genes was performed. Pathogenicity of MMR variants was assessed by splicing and multifactorial likelihood analyses. Genome-wide methylome analysis was performed by the Infinium Human Methylation 450K Bead Chip. The multigene panel analysis revealed the presence of two MMR gene truncating mutations not previously found. Of a total of 15 additional MMR variants identified, five -present in 6 unrelated individuals- were reclassified as pathogenic. In addition, 13 predicted deleterious variants in other CRC-predisposing genes were found in 12 probands. Methylome analysis detected one constitutionalMLH1epimutation, but no additional differentially methylated regions were identified in LLS compared to LS patients or cancer-free individuals. In conclusion, the use of an ad-hoc designed gene panel combined with pathogenicity assessment of variants allowed the identification of deleterious MMR mutations as well as new LLS candidate causal genes. Constitutional epimutations in non-LS-associated genes are not responsible for LLS

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.

Background: The prospective phase IV AVAMET study was undertaken to correlate response evaluation criteria in solid tumors (RECIST)-defined response rates with computed tomography-based morphological criteria (CTMC) and pathological response after liver resection of colorectal cancer metastases. Methods: Eligible patients were aged >/=18 years, with Eastern Cooperative Oncology Group (ECOG) performance status 0/1 and histologically-confirmed colon or rectal adenocarcinoma with measurable liver metastases. Preoperative treatment was bevacizumab (7.5 mg on day 1) + XELOX (oxaliplatin 130 mg/m(2), capecitabine 1000 mg/m(2) bid on days 1-14 q3w). After three cycles, response was evaluated by a multidisciplinary team. Patients who were progression-free and metastasectomy candidates received one cycle of XELOX before undergoing surgery 3-5 weeks later, followed by four cycles of bevacizumab + XELOX. Results: A total of 83 patients entered the study; 68 were eligible for RECIST, 67 for CTMC, and 51 for pathological response evaluation. Of these patients, 49% had a complete or partial RECIST response, 91% had an optimal or incomplete CTMC response, and 81% had a complete or major pathological response. CTMC response predicted 37 of 41 pathological responses versus 23 of 41 responses predicted using RECIST (p = 0.008). Kappa coefficients indicated a lack of correlation between the results of RECIST and morphological responses and between morphological and pathological response rates. Conclusion: CTMC may represent a better marker of pathological response to bevacizumab + XELOX than RECIST in patients with potentially-resectable CRC liver metastases